✦ LIBER ✦

Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer

✍ Scribed by Kazuhiko Yamada; Masao Nakao; Chikara Fukuyama; Hiroshi Nokihara; Noboru Yamamoto; Ikuo Sekine; Hideo Kunitoh; Yuichiro Ohe; Emiko Ohki; Junichi Hashimoto; Tomohide Tamura

Book ID: 108586542
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 288 KB
Volume: 101
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2009.01361.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I pharmacokinetic study of bexar

A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)

✍ Jordi Rodon; Charlotte D. Jacobs; Quincy Chu; Eric K. Rowinsky; Arturo Lopez-Ana 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 277 KB

Phase I study of paclitaxel, carboplatin

Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC)

✍ Yasushi Ono; Mitsunori Hino; Yuka Ueda; Ryoko Kamizuru; Masatoshi Omata; Takashi 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 123 KB

Phase I and pharmacokinetic study of car

Phase I and pharmacokinetic study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer

✍ M. Ichiki; R. Gohara; R. Fujiki; S. Hoashi; T. Rikimaru; H. Aizawa 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 214 KB

Phase I study of the combination of neda

Phase I study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer

✍ Kentaro Okuda; Takashi Hirose; Hiroo Ishida; Sojiro Kusumoto; Tomohide Sugiyama; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 321 KB

Phase II study of carboplatin combined w

Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer

✍ Lian Jiang; Dao-yuan Wang; Zhi-hua Zhu; Liang-fa Tang; Xin-heng Hou; Hong-da Zha 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 242 KB

Phase I study of intravenous ASA404 (vad

Phase I study of intravenous ASA404 (vadimezan) administered in combination with paclitaxel and carboplatin in Japanese patients with non-small cell lung cancer

✍ Toyoaki Hida; Motohiro Tamiya; Makoto Nishio; Nobuyuki Yamamoto; Tomonori Hirash 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB